Eukaryotic translation initiation factor 5A-2 involves in doxorubicin-induced epithelial-mesenchymal transition in oral squamous cell carcinoma cells
Conclusions: Our study strongly proved that combined treatment with GC7 may boost the therapeutic effect of doxorubicin in OSCC by inhibiting the EMT.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Liang Fang, Li Gao, Lei Xie, Guizhou Xiao Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Epithelial Cancer | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study